Embryofetopathy due to oral anticoagulant therapy (Q46697): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Condição causada pela exposição do embrião ou feto a anticoagulantes durante o período pré-natal. Essa doença pode se manifestar com anomalia do nervo óptico, atrofia óptica, anomalia da papila, cegueira ou atresia de coanas. | |||
| description / en | description / en | ||
A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia. | |||
Revision as of 15:28, 13 August 2026
A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | LD2F.02 |
||
| English | Embryofetopathy due to oral anticoagulant therapy |
A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia. |
